www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
New treatment for Glioblastoma. I reported previously ((11th Nov) the Hebrew University of Jerusalem’s breakthrough in glioblastoma (aggressive brain cancer) treatment. Now Sheba Medical Center researchers have developed SIXAC, a new six-amino-acid-based compound, that restricts the progression of glioblastoma.
https://www.timesofisrael.com/israel-researchers-say-new-drug-may-lead-to-cure-for-aggressive-brain-cancer/
Blood test for lung cancer. I reported previously (see here) on two Israeli startups (Nucleix and Medial EarlySign) developing blood tests for diagnosing early stage lung cancer. Here is another – Savicell, achieving a 91% success rate. Early detection gives the patient a 50-80% recovery chance. At late stage it is only 4%.
https://www.algemeiner.com/2018/12/20/israeli-company-creates-successful-blood-test-for-lung-cancer/
https://link.springer.com/article/10.1007/s00262-018-2173-5 http://www.savicell.com/
Device to spot melanoma. (TY WIN) Israeli startup Scade Medical has patented a prototype scanner, to diagnose early stage melanoma. BlueSky is based on DOSI (differential optical spectro-polarimetric imaging) technology invented by Ofir Aharon, whose mother contracted melanoma. It has already saved seven lives.
https://www.israel21c.org/moms-melanoma-leads-to-israeli-device-for-early-detection/
US approves cervical cancer diagnostic device. I reported previously (25th Sep) that Israel’s Biop had raised $2.2 million to fund its cervical cancer diagnosis device. Biop has just received US FDA approval for the device, which maps the cervix and identifies cancerous and precancerous cells in epithelial tissues.
https://www.calcalistech.com/ctech/articles/0,7340,L-3752348,00.html
Home diagnosis kit. (TY Arutz Sheva) Israeli startup Diagnoz.me has a smartphone system that can detect infections from home and send results to your doctor. Founder and CTO Tamir Epstein described the system on ILTV. Diagnoz.me just won the dHealth 2018 Summit and its NIS 3 million prize money.
https://www.youtube.com/watch?v=2I1weyrbn9Y
https://diagnoz.me/2018/12/17/diagnoz-me-wins-dhealth-2018/
The Origin/als aim to end ALS. A team of students at Israel’s Ben-Gurion University competed in the 2018 International Genetically Engineered Competition (iGEM) at MIT in Boston. The group presented findings on a new therapeutic approach for Amyotropic Lateral Sclerosis (ALS), known also as Lou Gehrig’s disease.
http://www.winnipegjewishreview.com/article_detail.cfm?id=6845&sec=2
Novatis backs Israeli anti-cancer biotech. I reported previously (see here) on Israeli biotech Ayala and its personalized cancer treatment. It is already partnering with Bristol-Myers Squibb. Now multinational Novatis has made a $|10 million investment in Ayala, focusing on the aggressive blood cancer multiple myeloma.
https://www.calcalistech.com/ctech/articles/0,7340,L-3752698,00.html
Lonza opens center for Israeli cooperation. (TY Calcalistech) Swiss biotech multinational Lonza has opened an innovation center in Haifa. Its aim is to partner “with Israeli talent in academia, medical institutions and early-stage innovative companies”. Lomza sees Israel’s technologies providing new healthcare solutions.
https://www.lonza.com/about-lonza/media-center/news/Tensid/2018-11-19-08-45-English.aspx
https://www.youtube.com/watch?v=rcKJlKWpz_8
Amgen partners Israeli biomed. (TY Calcalistech) I reported previously (see here) on Israel’s Entera Bio and its treatment for hypoparathyroidism. Entera Bio has just signed a research and licensing agreement with US multinational Amgen to develop a new oral molecule-based treatment that currently is given via IV or injection.
https://investors.enterabio.com/news-releases/news-release-details/entera-bio-and-amgen-enter-strategic-research-collaboration https://www.enterabio.com/